These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093 [TBL] [Abstract][Full Text] [Related]
31. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives. DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760 [No Abstract] [Full Text] [Related]
32. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. Merino R; Iwamoto M; Fossati L; Izui S J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378 [TBL] [Abstract][Full Text] [Related]
33. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus. Mahowald ML; Dalmasso AP Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796 [TBL] [Abstract][Full Text] [Related]
34. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592 [TBL] [Abstract][Full Text] [Related]
35. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus. Fournel S; Muller S Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425 [TBL] [Abstract][Full Text] [Related]
36. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance. Wither J; Vukusic B J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382 [TBL] [Abstract][Full Text] [Related]
37. Auto-antibodies specific for lymphocyte surface antigens--a review. Revillard JP; Rivera S; Robert M Comp Immunol Microbiol Infect Dis; 1980; 3(3):261-75. PubMed ID: 7009042 [No Abstract] [Full Text] [Related]
38. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [TBL] [Abstract][Full Text] [Related]
39. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. Monk CR; Spachidou M; Rovis F; Leung E; Botto M; Lechler RI; Garden OA Arthritis Rheum; 2005 Apr; 52(4):1180-4. PubMed ID: 15818683 [TBL] [Abstract][Full Text] [Related]